Cargando…
A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients
BACKGROUND: To reveal roles of reactive oxygen species (ROS) status in chemotherapy resistance and to develop a ROS scoring system for prognosis prediction in ovarian cancer. METHODS: We tested the sensitizing effects of ROS elevating drugs to cisplatin (cDDP) in ovarian cancer both in vitro and in...
Autores principales: | Sun, Chaoyang, Guo, Ensong, Zhou, Bo, Shan, Wanying, Huang, Jia, Weng, Danhui, Wu, Peng, Wang, Changyu, Wang, Shixuan, Zhang, Wei, Gao, Qinglei, Xu, Xiaoyan, Wang, Beibei, Hu, Junbo, Ma, Ding, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839150/ https://www.ncbi.nlm.nih.gov/pubmed/31703584 http://dx.doi.org/10.1186/s12885-019-6288-7 |
Ejemplares similares
-
Correction to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients
por: Sun, Chaoyang, et al.
Publicado: (2020) -
HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells
por: Lu, Hao, et al.
Publicado: (2016) -
The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients
por: Zhou, Bo, et al.
Publicado: (2019) -
Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo
por: Zhou, Bo, et al.
Publicado: (2019) -
Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer
por: Xia, Xi, et al.
Publicado: (2011)